Terms: = Prostate cancer AND uPA
263 results:
1. A Microfluidics-Assisted Double-Barreled Nanobioconjugate Synthesis Introducing Aprotinin as a New Moonlight Nanocarrier Protein: Tested toward Physiologically Relevant 3D-Spheroid Models.
Nazir F; Munir I; Yesiloz G
ACS Appl Mater Interfaces; 2024 Apr; 16(15):18311-18326. PubMed ID: 38564228
[TBL] [Abstract] [Full Text] [Related]
2. In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK.
Pham DD; Pham TH; Bui TH; Britikova EV; Britikov VV; Bocharov EV; Usanov SA; Phan VC; Le TBT
Mol Biol Rep; 2024 Jan; 51(1):130. PubMed ID: 38236367
[TBL] [Abstract] [Full Text] [Related]
3. The roles of proteases in prostate cancer.
Koistinen H; Kovanen RM; Hollenberg MD; Dufour A; Radisky ES; Stenman UH; Batra J; Clements J; Hooper JD; Diamandis E; Schilling O; Rannikko A; Mirtti T
IUBMB Life; 2023 Jun; 75(6):493-513. PubMed ID: 36598826
[TBL] [Abstract] [Full Text] [Related]
4. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
Clanchy FIL; Huang YS; Ogbechi J; Darlington LG; Williams RO; Stone TW
Front Immunol; 2022; 13():832989. PubMed ID: 35371018
[TBL] [Abstract] [Full Text] [Related]
5. Roles of the Na
Li X; Buckley B; Stoletov K; Jing Y; Ranson M; Lewis JD; Kelso M; Fliegel L
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948058
[TBL] [Abstract] [Full Text] [Related]
6. RelB promotes the migration and invasion of prostate cancer DU145 cells via exosomal ICAM1 in vitro.
Li W; Xu J; Cheng L; Zhao C; Zhang L; Shao Q; Guo F
Cell Signal; 2022 Mar; 91():110221. PubMed ID: 34933092
[TBL] [Abstract] [Full Text] [Related]
7. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
[TBL] [Abstract] [Full Text] [Related]
8. Self-assembled chitosan polymer intercalating peptide functionalized gold nanoparticles as nanoprobe for efficient imaging of urokinase plasminogen activator receptor in cancer diagnostics.
Shahdeo D; Kesarwani V; Suhag D; Ahmed J; Alshehri SM; Gandhi S
Carbohydr Polym; 2021 Aug; 266():118138. PubMed ID: 34044952
[TBL] [Abstract] [Full Text] [Related]
9. The malignancy index is a robust predictor of prostate cancer.
Serafin AM; Chinhengo A; Akudugu JM
Discov Med; 2020; 29(158):181-189. PubMed ID: 33007193
[TBL] [Abstract] [Full Text] [Related]
10. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-κB system.
Yang B; Zhang D; Qian J; Cheng Y
Mol Cell Biochem; 2020 Nov; 474(1-2):199-208. PubMed ID: 32737771
[TBL] [Abstract] [Full Text] [Related]
11. Ganoderma lucidum: A rational pharmacological approach to surmount cancer.
Ahmad MF
J Ethnopharmacol; 2020 Oct; 260():113047. PubMed ID: 32504783
[TBL] [Abstract] [Full Text] [Related]
12. HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in prostate cancer Progression.
Anselmino N; Bizzotto J; Sanchis P; Lage-Vickers S; Ortiz E; Valacco P; Paez A; Labanca E; Meiss R; Navone N; Cotignola J; Vazquez E; Gueron G
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32197509
[TBL] [Abstract] [Full Text] [Related]
13. Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.
Kimura S; D'Andrea D; Iwata T; Foerster B; Janisch F; Parizi MK; Moschini M; Briganti A; Babjuk M; Chlosta P; Karakiewicz PI; Enikeev D; Rapoport LM; Seebacher V; Egawa S; Abufaraj M; Shariat SF
World J Urol; 2020 Oct; 38(10):2501-2511. PubMed ID: 31797075
[TBL] [Abstract] [Full Text] [Related]
14. Graphene nanosheets as an electric mediator for ultrafast sensing of urokinase plasminogen activator receptor-A biomarker of cancer.
Roberts A; Tripathi PP; Gandhi S
Biosens Bioelectron; 2019 Sep; 141():111398. PubMed ID: 31176112
[TBL] [Abstract] [Full Text] [Related]
15. Naringenin Attenuated prostate cancer Invasion
Han KY; Chen PN; Hong MC; Hseu YC; Chen KM; Hsu LS; Chen WJ
Anticancer Res; 2018 Dec; 38(12):6753-6758. PubMed ID: 30504386
[TBL] [Abstract] [Full Text] [Related]
16. A Fluorescent Carbon Nanotube Sensor Detects the Metastatic prostate cancer Biomarker upa.
Williams RM; Lee C; Heller DA
ACS Sens; 2018 Sep; 3(9):1838-1845. PubMed ID: 30169018
[TBL] [Abstract] [Full Text] [Related]
17. The malignancy index in plasma samples as a prostate cancer biomarker.
Serafin AM; Chinhengo A; Fernandez P; Akudugu JM
Discov Med; 2018 May; 25(139):235-242. PubMed ID: 29906406
[TBL] [Abstract] [Full Text] [Related]
18. Aspirin Inhibits IKK-β-mediated prostate cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract] [Full Text] [Related]
19. Copenhagen upaR prostate cancer (CuPCa) database: protocol and early results.
Lippert S; Berg KD; Høyer-Hansen G; Lund IK; Iversen P; Christensen IJ; Brasso K; Røder MA
Biomark Med; 2016; 10(2):209-16. PubMed ID: 26764285
[TBL] [Abstract] [Full Text] [Related]
20. Components of the Plasminogen-Plasmin System as Biologic Markers for cancer.
McMahon BJ; Kwaan HC
Adv Exp Med Biol; 2015; 867():145-56. PubMed ID: 26530365
[TBL] [Abstract] [Full Text] [Related]
[Next]
